Cytotoxicity Evaluation of Methanol Extracts of Some Medicinal Plants on P19 Embryonal Carcinoma Cells
Sara Soltanian, Mahboubeh Sheikhbahaei, neda mohamadi.
Abstract
Strategies for conventional cancer treatment including chemotherapy and radiation therapy decrease the bulk of tumor cells but a population of cancer stem cells (CSCs) remains. CSCs comprise a very small population in many cancers with ability of self-renewal and differentiation. Drug resistance of CSCs lead to their survival after treatment which finally result in cancer recurrence. It has been shown that many phytochemicals and plant extracts are able to target CSCs and may be a true therapeutic strategy for eradicating cancer. In this study, we evaluated the in vitro cytotoxic activity of methanol extracts of four medicinal plants against P19 embryonal carcinoma cell which is considered as a CSC. Trypan Blue exclusion assay and MTT assay were used for evaluation of plant extract cytotoxicity. Morus alba showed the highest cytotoxic effect on P19 cells which is followed by Eucalyptus camaldulensis and Zataria multiflora and the least cytotoxicity was found in Circhorium intybus. Although Morus alba methanol extract showed the most potent anti-proliferative activity and could be investigated for finding pure anticancer compounds, but IC50 values> 100 of mentioned plant extracts after 48, 96 and 144 h incubation period indicates their weak cytotoxicity against P19 cells.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!